Skip to main content
December 8, 2024
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Olaparib
Breast Cancer Overviews
Precision Cancer Medicines and Breast Cancer
By Dr. C.H. Weaver M.D.
Sep 26, 2023
Ovarian Cancer Treatment
Update on PARP Inhibitors & Other Precision Cancer Medicines for Ovarian Cancer
By Dr. C.H. Weaver M.D.
Oct 11, 2023
Breast Cancer Treatment
PARP Inhibitors improve outcomes in BRCA mutated breast cancer. FDA approves Lynparza for treatment of TNBC and early stage breast cancer.
By Dr. C.H. Weaver M.D.
Jun 1, 2023
Prostate Cancer Treatment
PARP Inhibitors - Effective in Men with BRCA-Mutant Prostate Cancer
By Dr. C.H. Weaver M.D.
Aug 16, 2023
Ovarian Cancer Treatment
Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer
By Dr. C.H. Weaver M.D.
Jan 17, 2023
Ovarian Cancer Overviews
Treatment & Management of Ovarian Cancer
By Dr. C.H. Weaver M.D.
Aug 13, 2022
Ovarian Cancer Treatment
Rubraca Significantly Improves Ovarian Cancer Treatment
By Dr. C.H. Weaver M.D.
Apr 1, 2022
CLOSE
CLOSE
CLOSE
CLOSE